New surveillance guidelines for Li-Fraumeni and hereditary TP53 related cancer syndrome: implications for germline TP53 testing in breast cancer

被引：0
|
作者：
D. Gareth Evans
Emma R. Woodward
机构：
[1] University of Manchester,Division of Evolution and Genomic Sciences, Manchester Centre for Genomic Medicine
[2] Manchester Academic Health Sciences Centre (MAHSC),undefined
[3] St Mary’s Hospital,undefined
[4] Manchester University Hospitals NHS Foundation Trust,undefined
来源：
Familial Cancer | 2021年 / 20卷
关键词：
Breast cancer; Heritable ; -related cancer; Li-fraumeni syndrome; Penetrance; Sarcoma; Variant; MRI;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 7
页数：6
相关论文
共 50 条
  • [1] New surveillance guidelines for Li-Fraumeni and hereditary TP53 related cancer syndrome: implications for germline TP53 testing in breast cancer
    Evans, D. Gareth
    Woodward, Emma R.
    FAMILIAL CANCER, 2021, 20 (01) : 1 - 7
  • [2] Germline TP53 mutations and Li-Fraumeni syndrome
    Varley, JM
    HUMAN MUTATION, 2003, 21 (03) : 313 - 320
  • [3] A novel germline mutation of TP53 with breast cancer diagnosed as Li-Fraumeni syndrome
    Kai, Masaya
    Kubo, Makoto
    Shikada, Sawako
    Hayashi, Saori
    Morisaki, Takafumi
    Yamada, Mai
    Takao, Yuka
    Shimazaki, Akiko
    Harada, Yurina
    Kaneshiro, Kazuhisa
    Mizuuchi, Yusuke
    Shindo, Koji
    Nakamura, Masafumi
    SURGICAL CASE REPORTS, 2022, 8 (01)
  • [4] Assessing germline TP53 mutations in cancer patients: insights into Li-Fraumeni syndrome and genetic testing guidelines
    Danishevich, Anastasiia
    Fedorova, Daria
    Bodunova, Natalia
    Makarova, Maria
    Byakhova, Maria
    Semenova, Anna
    Galkin, Vsevolod
    Litvinova, Maria
    Nikolaev, Sergey
    Efimova, Irina
    Osinin, Pavel
    Lisitsa, Tatyana
    Khakhina, Anastasiya
    Shipulin, German
    Nasedkina, Tatiana
    Shumilova, Syuykum
    Gusev, Oleg
    Bilyalov, Airat
    Shagimardanova, Elena
    Shigapova, Leyla
    Nemtsova, Marina
    Sagaydak, Olesya
    Woroncow, Mary
    Gadzhieva, Saida
    Khatkov, Igor
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2025, 23 (01)
  • [5] TP53 MUTATIONS AND LI-FRAUMENI SYNDROME
    Hainaut, P.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 703 - 703
  • [6] The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations
    Finkova, Alena
    Vazna, Alzbeta
    Hrachovina, Ondrej
    Bendova, Sarka
    Prochazkova, Kamila
    Sedlacek, Zdenek
    CANCER GENETICS AND CYTOGENETICS, 2009, 193 (01) : 63 - 66
  • [7] A new germline TP53 gene mutation in a family with Li-Fraumeni syndrome
    DockhornDwomiczak, B
    Wolff, J
    Poremba, C
    Schafer, KL
    Ritter, J
    Gullotta, F
    Jurgens, H
    Bocker, W
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (08) : 1359 - 1365
  • [8] Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort
    Masciari, Serena
    Dillon, Deborah A.
    Rath, Michelle
    Robson, Mark
    Weitzel, Jeffrey N.
    Balmana, Judith
    Gruber, Stephen B.
    Ford, James M.
    Euhus, David
    Lebensohn, Alexandra
    Telli, Melinda
    Pochebit, Stephen M.
    Lypas, Georgios
    Garber, Judy E.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (03) : 1125 - 1130
  • [9] Germline TP53 Mutations and the Changing Landscape of Li-Fraumeni Syndrome
    Kamihara, Junne
    Rana, Huma Q.
    Garber, Judy E.
    HUMAN MUTATION, 2014, 35 (06) : 654 - 662
  • [10] A NOVEL GERMLINE TP53 MUTATION IN A PATIENT WITH LI-FRAUMENI SYNDROME
    Douglass, David
    Farrar, Jason
    Stine, Kimo
    PEDIATRIC BLOOD & CANCER, 2019, 66
12345